Author:
Shah Koonal Kirit,Mestre-Ferrandiz Jorge,Towse Adrian,Smyth Emily Nash
Abstract
Pharmaceutical manufacturers, regulators, patients, providers, and payers all have a shared interest in improving health outcomes for patients with cancer. Each plays an important role in helping to achieve this common goal. Pharmaceutical manufacturers seek to develop new medicines that are supported by robust and clinically meaningful evidence of their safety, efficacy, and effectiveness. Regulators authorize these medicines based on evaluations of their safety and efficacy. Patients and providers together make treatment decisions and desire access to the most effective treatment options. Payers appraise new medicines with the goal of ensuring access to those medicines that constitute efficient uses of healthcare expenditure. Profits generated from the sale of the medicines provide a return to the manufacturer, which helps to drive continued research and development in an effort to improve patient health outcomes and societal well-being. Many payers have initiated health technology assessment (HTA) activities to inform decision making in light of the rising costs of health care. Given the financial constraints imposed as a result of the global economic crisis, HTAs are likely to become increasingly important as payers seek value for money solutions to major health problems. Successful collaboration and aligning incentives across stakeholders is critical to ensuring that patients are able to access the most effective medicines.
Publisher
Cambridge University Press (CUP)
Reference19 articles.
1. The impact of mammography and adjuvant therapy on U.S. breast cancer mortality (1975-2000): collective results from the cancer intervention and surveillance modeling Network;J Natl Cancer Inst.,2006
2. Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions
3. The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000
4. Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
5. The impact of health technology assessments: an international comparison;Kanavos;Euro Observer.,2010
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献